MARKET

CDT

CDT

Conduit Pharms
NASDAQ
0.4101
-0.0119
-2.82%
Opening 12:10 05/08 EDT
OPEN
0.4093
PREV CLOSE
0.4220
HIGH
0.4370
LOW
0.3909
VOLUME
355.70K
TURNOVER
--
52 WEEK HIGH
350.00
52 WEEK LOW
0.3700
MARKET CAP
4.65M
P/E (TTM)
-0.0200
1D
5D
1M
3M
1Y
5Y
1D
CONDUIT PHARMACEUTICALS INC - FILES NEW PATENT FOR AZD5904
Reuters · 3h ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 1d ago
Conduit Pharmaceuticals Approves Reverse Stock Split Amendments
TipRanks · 1d ago
Weekly Report: what happened at CDT last week (0428-0502)?
Weekly Report · 3d ago
Weekly Report: what happened at CDT last week (0421-0425)?
Weekly Report · 04/28 12:28
Conduit Pharmaceuticals files to sell 2.1M shares of common stock for holders
Seeking Alpha · 04/22 21:41
CONDUIT PHARMACEUTICALS FILES PROSPECTUS RELATES TO OFFER, RESALE OF UP TO 2.2 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS
Reuters · 04/22 21:26
Weekly Report: what happened at CDT last week (0414-0418)?
Weekly Report · 04/21 12:27
More
About CDT
More
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto’s Thyroiditis (HT and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).
Recently
Symbol
Price
%Change
    CDT
  • 0.4101
  • -2.82%

Webull offers Conduit Pharmaceuticals Inc stock information, including NASDAQ: CDT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDT stock methods without spending real money on the virtual paper trading platform.